Paricalcitol for the Treatment of Immunoglobulin A Nephropathy

NCT00599963 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding problem.

Conditions

IgA Nephropathy

Interventions

DRUG: paricalcitol

Sponsor

Chinese University of Hong Kong